Luxfer Holdings PLC
NYSE:LXFRIndustrial - Machinery
+$0.51 today
- Market cap
- $464.28M
- Beta
- 1.12
- P/E (TTM)
- 86.4
- EPS (TTM)
- $0.22
- Dividend yield
- 2.76%
Volume 0.58M
Average 0.18M
LXFR Other Financing Activities
Financing cash flows not reported separately.
Luxfer Holdings PLCNYSE: LXFR
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities grows, but more slowly than its trailing trend
Q1 FY2026 other financing activities of $1.5M (cash outflow) rose 275.0% year over year, behind the +1457.5% change in trailing-twelve-month other financing activities. Sequentially, it fell 85.9% from the prior quarter. Over 3 fiscal years it compounded at -17.0% a year.
Context
- Other financing activities amounted to 0.2% of revenue in FY2025, unchanged from a year earlier.
- Other financing activities grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +275.0% toward the trailing-twelve-month pace of +1457.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (800K) USD
- Year-over-year change
- -60.0%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (800K) | -60.0% |
| FY2024 | 2024-12-31 | (500K) | +16.7% |
| FY2023 | 2023-12-31 | (600K) | +57.1% |
| FY2022 | 2022-12-31 | (1.4M) | +44.0% |
| FY2021 | 2021-12-31 | (2.5M) | — |
Other Financing Activities vs competitors
How LXFR compares with its peers on the latest reported figures
- LXFR's LTM Mar 2026 other financing activities of $12.41M is the 2nd largest of the 11 companies compared; the peer median is $307K.
- Its year-over-year change of +1457.5% is the highest of 9, against a peer median of +51.0%.
- Other financing activities amounts to 3.3% of revenue for LXFR, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $12.6M | +128.8% | +10.2% | 1.9% | |
| LTM Mar 2026 | $12.41M | +1457.5% | -17.0% | 3.3% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $10.44M | -4.9% | — | 6.2% |
| LTM Mar 2026 | $9.33M | +137.6% | -41.9% | 1.4% | |
| LTM Mar 2026 | $9.25M | +99.1% | — | 2.1% | |
| LTM Mar 2026 | $3.5M | +2.9% | -60.6% | 0.2% | |
| LTM Mar 2026 | $2.05M | — | — | 0.1% | |
| LTM Mar 2026 | $910.94K | +569.8% | — | 0.2% | |
| LTM Mar 2026 | $414K | -91.5% | -31.4% | — | |
| LTM Mar 2026 | $200K | -93.8% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding LXFR) | $307K | +51.0% | -36.6% | 0.2% | |
Competitors are the stored peer set for LXFR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 30M | 32M | (2.6M) | 18.3M | 7.7M |
| Depreciation & Amortization | 15.6M | 18M | 12.7M | 13.4M | 9.9M |
| Deferred Income Tax | (1.6M) | 8.7M | (600K) | 1.1M | 6.2M |
| Stock-Based Compensation | 2.8M | 2.5M | 2.8M | 3.5M | 3.6M |
| Change in Working Capital | (1.2M) | (46.6M) | (8M) | 8.9M | (8.9M) |
| Accounts Receivables | (9.8M) | (25.3M) | 16.6M | (4.3M) | 4.3M |
| Inventory | (15.3M) | (25M) | 16.6M | (4.1M) | (6.7M) |
| Accounts Payables | 11.4M | 21.3M | (19M) | 4.8M | (5.7M) |
| Other Working Capital | 12.5M | (17.6M) | (22.2M) | 12.5M | (800K) |
| Other Non-Cash Items | (19.5M) | 1.3M | 22M | 5.9M | 15.5M |
| Operating Cash Flow | 26.1M | 15.9M | 26.3M | 51.1M | 34M |
| Capital Expenditures | (9.1M) | (8.3M) | (9.4M) | (10.3M) | (7.8M) |
| Acquisitions (Net) | 4.1M | (1M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (100K) | 3.6M | (100K) | 7.3M | 2.7M |
| Investing Cash Flow | (5.1M) | (5.7M) | (9.5M) | (3.4M) | (5.1M) |
| Debt Repayment | 6.4M | 24.8M | (10.2M) | (27.2M) | (7.2M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (6.4M) | (11.1M) | (2.7M) | (2.3M) | (3.1M) |
| Dividends Paid | (13.6M) | (14.2M) | (14M) | (14M) | (13.9M) |
| Other Financing Activities | (2.5M) | (1.4M) | (600K) | (500K) | (800K) |
| Financing Cash Flow | (16.1M) | (2M) | (27.5M) | (44M) | (25M) |
| Effect of Forex Changes | 0 | (1.7M) | 400K | 0 | 500K |
| Net Change in Cash | 4.9M | 6.5M | (10.3M) | 3.7M | 4.4M |
| Free Cash Flow | 17M | 7.6M | 16.9M | 40.8M | 26.2M |
Luxfer Holdings PLC
NYSE:LXFR
Intrinsic Alpha fair value
Locked
Current Price
$17.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.